Aria Care Partners Names New Chief Clinical Officer
The chief clinical officer's mission is to drive strategic enhancements to Aria's expanding portfolio of onsite ancillary care services. The company sees opportunities to optimize care models and realize innovative synergies between its service lines to benefit SNFs and their residents.
His wide-ranging operational and management experience includes recent tenure as Vice President of Operations at health plan firms Centivo and Eden Health. He previously held positions as a clinical support director and a practicing physician associate. In addition,
"Healthcare's rapid changes and evolving SNF resident needs are generating opportunities to bring new levels of care to our clients," said
Added
About Aria Care Partners
Aria Care Partners is the leading provider of onsite ancillary medical services for skilled nursing facilities. With more than 20 years of partnership with over 3,000 skilled nursing facilities, Aria Care Partners remains on the leading edge of innovative care delivery, understanding the connection between dental, vision, hearing, and podiatry services to resident health and well-being. With a unique combination of turnkey insurance solutions and innovative service delivery, Aria Care Partners is passionate about enriching every resident's quality of life and ensuring that every family knows their loved ones are well cared for. For more information, please visit www.ariacarepartners.com.
Media Contact:
(913) 594-3088
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/aria-care-partners-names-new-chief-clinical-officer-302539050.html
SOURCE Aria Care Partners
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Edwards Wins $18M FAA Designee Management System (DMS) Prime Task Order Through GET Joint Venture on FAA ITIPSS
- RedThread Study Reveals People Analytics Tech Market Reached $12.2B in 2025 as Growth Cools, Contracts Unbundle, and Vendors Reconsider their Customer Support
- Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share